Abstract:Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity. Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells. Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein. Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands. CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.

Synthetic Glycan Ligand Excludes CD22 from Antigen Receptor-Containing Lipid Rafts.

Neu5Gc-mediated high-affinity interaction is dispensable for CD22 cis-ligands to regulate B cell signaling

The Synaptic Recruitment of Lipid Rafts is Dependent on CD19-PI3K Module and Cytoskeleton Remodeling Molecules.

Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands

Suppressing Immune Responses Using Siglec Ligand-Decorated Anti-receptor Antibodies

Siglec-6 mediates the uptake of extracellular vesicles through a noncanonical glycolipid binding pocket

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

Abstract 6359: Structural insights into Siglec-15 reveal glycosylation dependency for interaction with T cells through integrin CD11b

N-glycosylation of mannose receptor (CD206) regulates glycan binding by C-type lectin domains

A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands

Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9

B-cell–independent sialylation of IgG

The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B-cell Lymphoma Therapy

Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell–cell interactions and signalling

The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation

Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression

CD226 Protein is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation Via Its First Extracellular Domain*

The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling

Receptor-independent, Lipid Dependent Mechanism of Syk Kinase Activation in Dendritic Cells (134.71)

CD3/TCR Complex-Associated Lymphocyte Activation Gene-3 Molecules Inhibit CD3/TCR Signaling